Understanding autoreactive T cells in healthy mice
Autoreactive CD4 T cells in healthy mice
This study looks at how certain immune cells in healthy mice can sometimes avoid being removed when they might attack the body’s own tissues, helping us understand what keeps these cells alive and how we can better manage autoimmune conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10841586 on NIH RePORTER |
What this research studies
This research investigates how certain T cells, which can react against the body's own tissues, are regulated in healthy mice. It focuses on the thymus, where T cells are supposed to be eliminated if they are potentially harmful. The study will explore how these autoreactive T cells can escape deletion and what factors contribute to their survival. By examining the responses of these cells to specific self-peptides, the research aims to uncover the mechanisms behind autoimmunity and the role of regulatory T cells in maintaining immune balance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune conditions or those at risk of developing such disorders.
Not a fit: Patients without any autoimmune conditions or those who are not at risk for autoimmune diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into preventing or treating autoimmune diseases in humans.
How similar studies have performed: Previous research has shown that understanding T cell regulation can lead to breakthroughs in treating autoimmune diseases, suggesting this approach has potential for success.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Ignatowicz, Leszek — Georgia State University
- Study coordinator: Ignatowicz, Leszek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.